Bionano Genomics, Inc. — Director's Dealing 2021

Dec 23, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Bionano Genomics, Inc. (BNGO)
CIK: 0001411690
Period of Report: 2021-12-21

Reporting Person: Wong Vincent Jung-Fai (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-12-21	Stock Option (Right to Buy)	$3.29	A	122054	Acquired	2031-12-20	Common Stock (122054)	Direct

Footnotes

F1: The shares vest in equal monthly installments over a three year period such that the option is fully vested on December 21, 2024, subject to full vesting acceleration upon a change in control (as defined in Bionano Genomic's equity incentive plan).